tiprankstipranks
Trending News
More News >
Sorrento Therapeutics (SRNE)
OTHER OTC:SRNE

Sorrento Therapeutics (SRNE) Revenue

Compare
5,242 Followers

Sorrento Therapeutics Revenue

Sorrento Therapeutics had a revenue of 15.03M in the quarter ending Jun 30, 2023, with -7.54%. This bring the company's revenue in the last twelve months to 64.27M, Decreased 5.87%. In the fiscal year ending Dec 31, 2022, Sorrento Therapeutics had annual revenue of 62.84M with 18.78% growth.
Revenue (ttm)
64.27M
Revenue Growth
P/S Ratio
0.08
Revenue/Employee
$66,216
Employees
949
Market Cap
$4.96M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2022
62.84M9.94M+118.78%
Dec 31, 2021
52.90M12.92M+132.31%
Dec 31, 2020
39.99M8.55M+127.21%
Dec 31, 2019
31.43M10.24M+148.31%
Dec 31, 2018
21.19M-130.66M+13.96%
Dec 31, 2017
151.86M143.70M+1,862.81%
Dec 31, 2016
8.15M